Plunkett Research Online: TrovaGene Inc.

TROVAGENE INC. (TROV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

TrovaGene Inc is a clinical-stage oncology therapeutics company, developingonvansertib, a first-in-class, 3rd generation, oral and highly-selectivePolo-like Kinase 1 (PLK1) inhibitor to treat patients with leukemia,lymphoma and solid tumor cancers. The company is making advancements in its clinical .....



TrovaGene Inc.
Ticker: TROV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858 217-4838
Fax: 858 217-4768
Address: 11055 Flintkote Avenue
Suite B
San Diego, CA 92121 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription
Thomas AdamsCEO/CFO/Chairman of the Board/Director
Mark ErlanderChief Scientific Officer
See More
TrovaGene Inc is a clinical-stage oncology therapeutics company, developingonvansertib, a first-in-class, 3rd generation, oral and highly-selectivePolo-like Kinase 1 (PLK1) inhibitor to treat patients with leukemia,lymphoma and solid tumor cancers. The company is making advancements in its clinical .....See More See More

Auditor: BDO USA, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: